Trial Profile
Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary) ; Sevoflurane
- Indications Anaesthesia; Pain
- Focus Therapeutic Use
- 11 Apr 2016 Status changed from not yet recruiting to completed.
- 13 Nov 2015 New trial record